ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681641 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681641; 2) Community: the network communities that were significantly associated with the response to NSC 681641; 3) Molecule: the relationships between components within communities and NSC 681641; 4) MDR: the compounds that were significantly associated with the NSC 681641.

NSC Compound Enrichment Correlation
NSC 729352 2,3-Dimethoxy-5,6-dihydro-5,11-diketo-6-(9H-fluoren-9-yl-met hoxy-carboxyamino)-propyl-8,9-methylenedioxy-11H-ideno[1,2-c ]isoquinoline 0.000931492155975116 0.35570569
NSC 682298 Camptothecin Derivative 0.00094423800811012 0.73732355
NSC 736081 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine 0.00094423800811012 0.072151889
NSC 107124 Camptothecin Derivative 0.000944238008110127 0.88865941
NSC 364830 Camptothecin Derivative 0.000944238008110127 0.81226986
NSC 295500 Camptothecin Derivative 0.00103112124545271 0.69180181
NSC 128887 Benzenebutanamide, N-(phenylmethyl)-4-bis(2-chloro- ethyl)amino]- 0.00115116014164088 0.59868571
NSC 720065 Vedelianin 0.00115116014164088 0.29415501
NSC 733883 6-(3-Chloropropyl)-5,6-dihydro-7-methoxy-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.00115116014164088 0.53206618
NSC 713196 Null 0.00116011782209854 0.33299057
Total:60  Current:3    [First] [Prev] [Next] [Last]